143 related articles for article (PubMed ID: 19225139)
1. A study of the treatment of Rett syndrome with folate and betaine.
Glaze DG; Percy AK; Motil KJ; Lane JB; Isaacs JS; Schultz RJ; Barrish JO; Neul JL; O'Brien WE; Smith EO
J Child Neurol; 2009 May; 24(5):551-6. PubMed ID: 19225139
[TBL] [Abstract][Full Text] [Related]
2. Rett syndrome: model of neurodevelopmental disorders.
Percy AK; Lane JB
J Child Neurol; 2005 Sep; 20(9):718-21. PubMed ID: 16225824
[TBL] [Abstract][Full Text] [Related]
3. S-adenosylmethionine and S-adenosylhomocysteine in plasma and cerebrospinal fluid in Rett syndrome and the effect of folinic acid supplementation.
Hagebeuk EE; Duran M; Abeling NG; Vyth A; Poll-The BT
J Inherit Metab Dis; 2013 Nov; 36(6):967-72. PubMed ID: 23392989
[TBL] [Abstract][Full Text] [Related]
4. Folinic acid supplementation in Rett syndrome patients does not influence the course of the disease: a randomized study.
Hagebeuk EE; Duran M; Koelman JH; Abeling NG; Vyth A; Poll-The BT
J Child Neurol; 2012 Mar; 27(3):304-9. PubMed ID: 21868372
[TBL] [Abstract][Full Text] [Related]
5. Effects of creatine supplementation in Rett syndrome: a randomized, placebo-controlled trial.
Freilinger M; Dunkler D; Lanator I; Item CB; Mühl A; Fowler B; Bodamer OA
J Dev Behav Pediatr; 2011; 32(6):454-60. PubMed ID: 21654506
[TBL] [Abstract][Full Text] [Related]
6. Methyl-CpG-binding protein 2 (MECP2) mutation type is associated with bone disease severity in Rett syndrome.
Caffarelli C; Gonnelli S; Pitinca MDT; Camarri S; Al Refaie A; Hayek J; Nuti R
BMC Med Genet; 2020 Jan; 21(1):21. PubMed ID: 32005172
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of CSF neurotransmitters and folate in 25 patients with Rett disorder and effects of treatment.
Temudo T; Rios M; Prior C; Carrilho I; Santos M; Maciel P; Sequeiros J; Fonseca M; Monteiro J; Cabral P; Vieira JP; Ormazabal A; Artuch R
Brain Dev; 2009 Jan; 31(1):46-51. PubMed ID: 18572337
[TBL] [Abstract][Full Text] [Related]
8. The diagnosis of autism in a female: could it be Rett syndrome?
Young DJ; Bebbington A; Anderson A; Ravine D; Ellaway C; Kulkarni A; de Klerk N; Kaufmann WE; Leonard H
Eur J Pediatr; 2008 Jun; 167(6):661-9. PubMed ID: 17684768
[TBL] [Abstract][Full Text] [Related]
9. Importance of Rett syndrome in child neurology.
Dunn HG
Brain Dev; 2001 Dec; 23 Suppl 1():S38-43. PubMed ID: 11738840
[TBL] [Abstract][Full Text] [Related]
10. Rett syndrome: controlled study of an oral opiate antagonist, naltrexone.
Percy AK; Glaze DG; Schultz RJ; Zoghbi HY; Williamson D; Frost JD; Jankovic JJ; del Junco D; Skender M; Waring S
Ann Neurol; 1994 Apr; 35(4):464-70. PubMed ID: 8154874
[TBL] [Abstract][Full Text] [Related]
11. [Clinical features and MECP2 mutations in children with Rett syndrome].
Zhao PW; He XL; Lin J; Wu GF; Yue X; Bi B; Hu JS; Liu ZS
Zhongguo Dang Dai Er Ke Za Zhi; 2014 Apr; 16(4):393-6. PubMed ID: 24750837
[TBL] [Abstract][Full Text] [Related]
12. Rett syndrome with and without detected MECP2 mutations: an attempt to redefine phenotypes.
Temudo T; Santos M; Ramos E; Dias K; Vieira JP; Moreira A; Calado E; Carrilho I; Oliveira G; Levy A; Barbot C; Fonseca M; Cabral A; Cabral P; Monteiro J; Borges L; Gomes R; Mira G; Pereira SA; Santos M; Fernandes A; Epplen JT; Sequeiros J; Maciel P
Brain Dev; 2011 Jan; 33(1):69-76. PubMed ID: 20116947
[TBL] [Abstract][Full Text] [Related]
13. Epilepsy and the natural history of Rett syndrome.
Glaze DG; Percy AK; Skinner S; Motil KJ; Neul JL; Barrish JO; Lane JB; Geerts SP; Annese F; Graham J; McNair L; Lee HS
Neurology; 2010 Mar; 74(11):909-12. PubMed ID: 20231667
[TBL] [Abstract][Full Text] [Related]
14. A Coordinated Attack: Rett Syndrome Therapeutic Development.
Gogliotti RG; Niswender CM
Trends Pharmacol Sci; 2019 Apr; 40(4):233-236. PubMed ID: 30905360
[TBL] [Abstract][Full Text] [Related]
15. Rett syndrome: a study of the face.
Allanson JE; Hennekam RC; Moog U; Smeets EE
Am J Med Genet A; 2011 Jul; 155A(7):1563-7. PubMed ID: 21626673
[TBL] [Abstract][Full Text] [Related]
16. Environmental enrichment intervention for Rett syndrome: an individually randomised stepped wedge trial.
Downs J; Rodger J; Li C; Tan X; Hu N; Wong K; de Klerk N; Leonard H
Orphanet J Rare Dis; 2018 Jan; 13(1):3. PubMed ID: 29321033
[TBL] [Abstract][Full Text] [Related]
17. The Changing Face of Survival in Rett Syndrome and MECP2-Related Disorders.
Tarquinio DC; Hou W; Neul JL; Kaufmann WE; Glaze DG; Motil KJ; Skinner SA; Lee HS; Percy AK
Pediatr Neurol; 2015 Nov; 53(5):402-11. PubMed ID: 26278631
[TBL] [Abstract][Full Text] [Related]
18. [Rett syndrome in a child treated with adrenocorticotrophic hormone].
Chen W; Liao JX; Chen L
Zhongguo Dang Dai Er Ke Za Zhi; 2009 Mar; 11(3):235-6. PubMed ID: 19292970
[No Abstract] [Full Text] [Related]
19. Clinical trials and treatment prospects.
Percy AK
Ment Retard Dev Disabil Res Rev; 2002; 8(2):106-11. PubMed ID: 12112736
[TBL] [Abstract][Full Text] [Related]
20. Determinants of sleep disturbances in Rett syndrome: Novel findings in relation to genotype.
Boban S; Wong K; Epstein A; Anderson B; Murphy N; Downs J; Leonard H
Am J Med Genet A; 2016 Sep; 170(9):2292-300. PubMed ID: 27255190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
